Video

Navigating Private Equity Ownership In The CDMO Space

Source: Outsourced Pharma

This segment of the Outsourced Pharma Live event, “The Unfiltered Truth About CDMO Selection” , addresses how to assess a CDMO's long-term financial stability under private equity ownership by outlining the exact questions sponsors should ask to uncover reinvestment plans and determine if leadership remains focused on core drug development operations. Featuring panelists Jana Spes, CEO & Co-founder, JT Biopharma Partners, and Christine Sheaffer, Manufacturing & Supply Consultant, Fmr, VP of Manufacturing & Supply, Spark Therapeutics.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)